Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers [Phase 4]
A Phase 4 clinical trial evaluating recombinant human chorionic gonadotropin (hCG) to prevent breast cancer in BRCA1 and BRCA2 mutation carr…
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer [Phase 2]
Phase 2 trial comparing tamoxifen with and without RAD001 in anti-aromatase resistant metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: 1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer [Phase 3]
Phase 3 trial comparing bevacizumab with taxane versus bevacizumab with exemestane as first-line treatment for metastatic breast cancer; stu…
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer [Phase 3]
A Phase 3 trial comparing eribulin mesylate to paclitaxel as first- or second-line therapy for recurrent stage IIIC-IV breast cancer has bee…
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer [Phase 3]
Phase 3 trial update comparing FS-1502 to T-DM1 for HER2-positive unresectable locally advanced or metastatic breast cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-31Clinical Trial Update: Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer [Phase 2]
Phase 2 trial investigating pembrolizumab with or without vorinostat and tamoxifen for estrogen receptor-positive breast cancer; trial termi…
-
CLINICAL_TRIALS trial_result · 2023-08-28Clinical Trial Update: Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer [Phase 2]
Phase 2 clinical trial update for oral SM-88 in metastatic HR+/HER2- breast cancer; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Investigation of Novel Surgical Imaging for Tumor Excision [Phase 3]
Phase 3 trial results for a novel surgical imaging agent used during tumor excision in breast cancer have been completed with results posted…
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial assessing ruxolitinib in combination with trastuzumab for metastatic HER2-positive breast cancer has completed with posted r…
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Anti-anxiety Biotics for Breast Cancer Survivors [NA]
Clinical trial update shows termination for a study on anti-anxiety antibiotics in breast cancer survivors; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: A Comparative Study of Pravastatin vs Placebo as Primary Prevention of Severe Subcutaneous Breast Fibrosis in Hyper-radiosensitive Identified Patients With Breast Cancer [Phase 3]
A Phase 3 trial comparing pravastatin to placebo for primary prevention of severe subcutaneous breast fibrosis in hyper-radiosensitive breas…
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluated alternative dosing of exemestane before surgery in postmenopausal women with early-stage estrogen recepto…
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer [Phase 2]
A Phase 2 neoadjuvant dose-dense regimen study for early HER2-positive breast cancer was terminated, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC [Phase 2]
Phase 2 trial evaluating margetuximab plus chemotherapy in Chinese patients with HER2-positive metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the combination of letrozole, everolimus, and TRC105 in postmenopausal women with hormone receptor-positive and…
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Study of Disitamab Vedotin and Anlotinib in Patients With HR-Negative, HER2-Low-Expressing Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update for disitamab vedotin with anlotinib in HR-negative, HER2-low-expressing metastatic breast cancer is ongoing w…
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Fathers and Mothers Invested in Lives of Their Youth (FAMILY) Study: A Pilot Intervention [NA]
Pilot intervention study (FAMILY) investigating parenting in the context of metastatic breast cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.
Pfizer's real-world study in Israel evaluated how palbociclib is used and what outcomes patients experience in metastatic breast cancer; the…
-
CLINICAL_TRIALS trial_result · 2023-08-15Clinical Trial Update: Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer [Phase 1, Phase 2]
A clinical trial update on managing severe chemotherapy-induced neutropenia in advanced breast cancer, completed phases 1 and 2.
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of TQB2440 Injection/Perjeta® Combined With Trastuzumab and Docetaxel in the Treatment of Patients With Early or Locally Advanced Breast Cancer. [Phase 3]
A Phase 3 clinical trial evaluating TQB2440 injected with Perjeta and trastuzumab plus docetaxel for early or locally advanced HER2-positive…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating IPI-549 in combination with front-line therapies for triple-negative breast cancer or renal cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Trial of Radiation Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation [Phase 2]
Phase 2 trial update on radiation fractionation schedules for once-a-day accelerated partial breast irradiation in breast cancer and DCIS.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating everolimus in patients with recurrent or metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer [Phase 1, Phase 2]
A clinical trial update reports on the study of Foretinib in combination with Lapatinib for metastatic breast cancer (Phase 1/2) which has c…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update for Reolysin in patients with metastatic breast cancer has completed recruitment and data collection.